🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will compare the safety and efficacy of sunitinib in combination...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2008-07
Trial ID
NCT00676650
Treatments Being Tested
A phase II study to allow patients with advanced kidney cancer access to su...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-09
Trial ID
NCT00338884
Treatments Being Tested
RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-09
Trial ID
NCT00397488
Treatments Being Tested
The purpose of this prospective study is to determine the safety and feasib...
Status
Completed
Location
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2011-04-11
Trial ID
NCT01286896
Treatments Being Tested
This is a 2-arm, randomized, open-label, international, multicenter study c...
Status
Active Not Recruiting
Location
Mayo Clinic Scottsdale
Start Date
2019-02-08
Trial ID
NCT03673501
Treatments Being Tested
This protocol allows subjects who have participated in a previous SU011248 ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-05
Trial ID
NCT00443534
Treatments Being Tested
This was a randomized, open-label, parallel group Phase III non inferiority...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-08-14
Trial ID
NCT00720941
Randomized, placebo-controlled, phase III study of regorafenib 160 mg once ...
Status
Completed
Location
Asan Medical Center, University of Ulsan College of Medicine
Start Date
2016-09
Trial ID
NCT02889328
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
To assess progression-free survival at the combination dose determined in t...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2007-06
Trial ID
NCT00417885
Treatments Being Tested